4/24
07:26 am
brkr
Bruker Announces Date and Time of First Quarter 2026 Earnings Release and Webcast [Yahoo! Finance]
Low
Report
Bruker Announces Date and Time of First Quarter 2026 Earnings Release and Webcast [Yahoo! Finance]
4/24
07:00 am
brkr
Bruker Announces Date and Time of First Quarter 2026 Earnings Release and Webcast
Low
Report
Bruker Announces Date and Time of First Quarter 2026 Earnings Release and Webcast
4/17
09:00 am
brkr
Bruker Spatial Biology Showcases High Fidelity Spatial Data and Integrated Multi-platform Workflows for Unprecedented Multiomic Insights at AACR 2026
Medium
Report
Bruker Spatial Biology Showcases High Fidelity Spatial Data and Integrated Multi-platform Workflows for Unprecedented Multiomic Insights at AACR 2026
4/17
06:34 am
brkr
Bruker Launches MyGenius PRO® High-Throughput Sample-to-Answer Molecular Diagnostics System at ESCMID 2026 [Yahoo! Finance]
Medium
Report
Bruker Launches MyGenius PRO® High-Throughput Sample-to-Answer Molecular Diagnostics System at ESCMID 2026 [Yahoo! Finance]
4/17
06:00 am
brkr
Bruker Expands Industry-Leading MALDI Biotyper® and IR Biotyper® Workflows for Microbial Identification and Outbreak Management
Medium
Report
Bruker Expands Industry-Leading MALDI Biotyper® and IR Biotyper® Workflows for Microbial Identification and Outbreak Management
4/17
06:00 am
brkr
Bruker Launches MyGenius PRO® High-Throughput Sample-to-Answer Molecular Diagnostics System at ESCMID 2026
Medium
Report
Bruker Launches MyGenius PRO® High-Throughput Sample-to-Answer Molecular Diagnostics System at ESCMID 2026
4/14
05:21 pm
brkr
Bruker (BRKR) had its price target lowered by Barclays PLC from $50.00 to $45.00. They now have an "overweight" rating on the stock.
Low
Report
Bruker (BRKR) had its price target lowered by Barclays PLC from $50.00 to $45.00. They now have an "overweight" rating on the stock.
4/13
07:00 am
brkr
Bruker Unveils New NMR Products and Workflow Solutions at ENC 2026
Low
Report
Bruker Unveils New NMR Products and Workflow Solutions at ENC 2026
4/7
07:00 am
brkr
Bruker Invests in Photothermal AFM-IR to Advance Semiconductor Research
Low
Report
Bruker Invests in Photothermal AFM-IR to Advance Semiconductor Research
4/1
07:00 am
brkr
Bruker Announces Appointment of Thierry Bernard to its Board of Directors
Low
Report
Bruker Announces Appointment of Thierry Bernard to its Board of Directors
3/31
01:07 pm
brkr
PreOmics GmbH and Biognosys AG Prevail in U.S. Patent Challenge
Low
Report
PreOmics GmbH and Biognosys AG Prevail in U.S. Patent Challenge
3/30
12:44 pm
brkr
Bruker (BRKR) had its price target lowered by Guggenheim from $58.00 to $50.00. They now have a "buy" rating on the stock.
Low
Report
Bruker (BRKR) had its price target lowered by Guggenheim from $58.00 to $50.00. They now have a "buy" rating on the stock.
3/30
06:18 am
brkr
Bruker (BRKR) had its "sell (d+)" rating reaffirmed by
Weiss Ratings.
Low
Report
Bruker (BRKR) had its "sell (d+)" rating reaffirmed by
Weiss Ratings.
3/23
08:31 am
brkr
Here's Why Bruker's (BRKR) Positive Momentum Returned in Q4 [Yahoo! Finance]
Low
Report
Here's Why Bruker's (BRKR) Positive Momentum Returned in Q4 [Yahoo! Finance]
2/25
07:00 am
brkr
Bruker Accelerates the Future of Diagnostic and Prognostic Spatial Proteomics with the Launch of CellScape XR
Low
Report
Bruker Accelerates the Future of Diagnostic and Prognostic Spatial Proteomics with the Launch of CellScape XR
2/24
07:00 am
brkr
Bruker Expands Collaboration with Noetik to Advance Tissue Foundational Models for Translational and Therapeutic Applications
Low
Report
Bruker Expands Collaboration with Noetik to Advance Tissue Foundational Models for Translational and Therapeutic Applications
2/23
07:00 am
brkr
Bruker Advances Functional Proteomics 2.0 with timsOmniTM Mass Spectrometry Proteoform Analysis for Deeper Insights into Disease Biology
Medium
Report
Bruker Advances Functional Proteomics 2.0 with timsOmniTM Mass Spectrometry Proteoform Analysis for Deeper Insights into Disease Biology
2/23
07:00 am
brkr
Bruker Announces Major Advancements at AGBT to Enable Complete High-Fidelity Spatial Biology Across the Biological Spectrum
Medium
Report
Bruker Announces Major Advancements at AGBT to Enable Complete High-Fidelity Spatial Biology Across the Biological Spectrum
2/19
08:00 am
brkr
3D Protein Structure Analysis Market Report 2026 Featuring Profiles of Merck, Bruker Corp., Thermo Fisher Scientific, JEOL, Spectris and Other Leading Players [Yahoo! Finance]
Low
Report
3D Protein Structure Analysis Market Report 2026 Featuring Profiles of Merck, Bruker Corp., Thermo Fisher Scientific, JEOL, Spectris and Other Leading Players [Yahoo! Finance]
2/13
11:44 am
brkr
Bruker (NASDAQ:BRKR) had its price target lowered by analysts at TD Cowen from $53.00 to $43.00. They now have a "hold" rating on the stock.
Low
Report
Bruker (NASDAQ:BRKR) had its price target lowered by analysts at TD Cowen from $53.00 to $43.00. They now have a "hold" rating on the stock.
2/13
10:57 am
brkr
Bruker (NASDAQ:BRKR) had its "neutral" rating reaffirmed by analysts at UBS Group AG.
Low
Report
Bruker (NASDAQ:BRKR) had its "neutral" rating reaffirmed by analysts at UBS Group AG.
2/13
10:16 am
brkr
Bruker (NASDAQ:BRKR) had its "sell" rating reaffirmed by analysts at The Goldman Sachs Group, Inc..
Low
Report
Bruker (NASDAQ:BRKR) had its "sell" rating reaffirmed by analysts at The Goldman Sachs Group, Inc..
2/13
08:05 am
brkr
Bruker (NASDAQ:BRKR) had its "neutral" rating reaffirmed by analysts at Citigroup Inc..
Low
Report
Bruker (NASDAQ:BRKR) had its "neutral" rating reaffirmed by analysts at Citigroup Inc..
2/13
07:17 am
brkr
Bruker (NASDAQ:BRKR) had its "overweight" rating reaffirmed by analysts at Barclays PLC.
Low
Report
Bruker (NASDAQ:BRKR) had its "overweight" rating reaffirmed by analysts at Barclays PLC.
2/12
04:23 pm
brkr
Bruker Corp (BRKR) Q4 2025 Earnings Call Highlights: Navigating Challenges and Setting the ... [Yahoo! Finance]
Medium
Report
Bruker Corp (BRKR) Q4 2025 Earnings Call Highlights: Navigating Challenges and Setting the ... [Yahoo! Finance]